3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Myelodysplastic Syndromes
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Ototoxicity
1
Neurotoxicity Syndromes
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Microbiota
1
Metabolic Diseases
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Immunologic Deficiency Syndromes
1
Immunoglobulin Light-chain Amyloidosis
1
Hormone Refractory Prostate Cancer
1
Fatigue
1
Central Nervous System Neoplasms
1
Breast Cancer Organoids
1
Breast Cancer Metastatic
1
Brain Neoplasms
1
Interventions
Patient Reported Outcome Measures
1
Cyclophosphamide
1
Cell Separation
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Breast Cancer Metastatic
×
Cyclophosphamide
×
Clear all
NCT04350021
2024-01-17
METRO
Vastra Gotaland Region
Completed
40 enrolled